Nancy Stambler
About
Nancy Stambler is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Nancy Stambler has authored 68 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 26 papers in Pulmonary and Respiratory Medicine and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nancy Stambler's work include Prostate Cancer Treatment and Research (25 papers), Radiopharmaceutical Chemistry and Applications (24 papers) and Gastrointestinal motility and disorders (20 papers). Nancy Stambler is often cited by papers focused on Prostate Cancer Treatment and Research (25 papers), Radiopharmaceutical Chemistry and Applications (24 papers) and Gastrointestinal motility and disorders (20 papers). Nancy Stambler collaborates with scholars based in United States, Canada and Hungary. Nancy Stambler's co-authors include Jesse M. Cedarbaum, Dana Hilt, Arline Nakanishi, Errol Malta, Robert J. Israel, Vivien Wong, Tess Lin, Jessica Jensen, Neal E. Slatkin and Michael A. Gorin and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.
In The Last Decade
Nancy Stambler
66 papers receiving 5.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nancy Stambler United States | 24 | 2.8k | 1.5k | 778 | 695 | 628 | 68 | 5.2k | ||
| Robert D. Henderson Australia | 43 | 3.0k 1.1× | 1.3k 0.9× | 1.1k 1.4× | 1.0k 1.5× | 876 1.4× | 228 | 6.8k | ||
| Klaus Tatsch Germany | 55 | 3.5k 1.3× | 1.2k 0.8× | 858 1.1× | 784 1.1× | 2.8k 4.4× | 229 | 10.0k | ||
| Richard J. Barohn United States | 54 | 5.5k 2.0× | 1.7k 1.2× | 314 0.4× | 671 1.0× | 832 1.3× | 191 | 10.0k | ||
| David Lacomis United States | 38 | 2.3k 0.8× | 557 0.4× | 321 0.4× | 328 0.5× | 288 0.5× | 139 | 4.6k | ||
| Teresa Ribalta Spain | 36 | 1.8k 0.6× | 706 0.5× | 359 0.5× | 384 0.6× | 251 0.4× | 118 | 5.0k | ||
| Julia E. Crook United States | 46 | 1.2k 0.4× | 272 0.2× | 1.3k 1.7× | 1.3k 1.9× | 198 0.3× | 148 | 5.8k | ||
| Gordon Gilbert United States | 42 | 3.8k 1.4× | 1.8k 1.2× | 574 0.7× | 2.5k 3.6× | 168 0.3× | 198 | 8.3k | ||
| Jun Takahashi Japan | 47 | 2.3k 0.8× | 467 0.3× | 1.5k 1.9× | 1.4k 2.0× | 1.4k 2.3× | 324 | 9.7k | ||
| David Hilton‐Jones United Kingdom | 45 | 2.7k 1.0× | 533 0.4× | 188 0.2× | 640 0.9× | 232 0.4× | 142 | 6.2k | ||
| Shigeru Tsunoda Japan | 29 | 368 0.1× | 386 0.3× | 1.0k 1.3× | 929 1.3× | 116 0.2× | 180 | 3.0k |
Countries citing papers authored by Nancy Stambler
Since
Specialization
Citations
This map shows the geographic impact of Nancy Stambler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Stambler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Stambler more than expected).
Fields of papers citing papers by Nancy Stambler
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nancy Stambler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Stambler. The network helps show where Nancy Stambler may publish in the future.
Co-authorship network of co-authors of Nancy Stambler
This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Stambler. A scholar is included among the top collaborators of Nancy Stambler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Stambler. Nancy Stambler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mehta, Neel, Neal E. Slatkin, Robert J. Israel, Nancy Stambler, & Eric D. Shah. (2023). Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness. Journal of Pain Research. Volume 16. 3529–3543.
2.
Shah, Eric D., Bruce Chamberlain, Michelle Rhiner, et al.. (2023). Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials. Journal of Pain Research. Volume 16. 395–406.
3.
Morris, Michael J., Steven P. Rowe, Michael A. Gorin, et al.. (2021). Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study. Clinical Cancer Research. 27(13). 3674–3682.
4.
Liao, Solomon, Neal E. Slatkin, & Nancy Stambler. (2021). The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation. Drugs & Aging. 38(6). 503–511.
5.
Peacock, W. Frank, Neal E. Slatkin, Robert J. Israel, & Nancy Stambler. (2021). First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis. Journal of Emergency Medicine. 62(2). 231–239.
6.
Chamberlain, Bruce, Michelle Rhiner, Neal E. Slatkin, Nancy Stambler, & Robert J. Israel. (2021). Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies. Journal of Pain Research. Volume 14. 2687–2697.
7.
Chin, Bennett B., Richard B. Noto, Joseph S. Dillon, et al.. (2020). PD31-06 UPDATED LONG-TERM SURVIVAL AND SAFETY FROM A MULTI-CENTER, OPEN-LABEL, PIVOTAL PHASE 2 STUDY OF AZEDRA® IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC PHEOCHROMOCYTOMA OR PARAGANGLIOMA. The Journal of Urology. 203. e632–e632.
8.
Pryma, Daniel A., Bennett B. Chin, Richard B. Noto, et al.. (2018). Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma. Journal of Nuclear Medicine. 60(5). 623–630.
9.
Rauck, Richard, Neal E. Slatkin, Nancy Stambler, & Robert J. Israel. (2018). Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain. Journal of Pain Research. Volume 12. 139–150.
10.
Rauck, Richard, et al.. (2016). Randomized, Double‐Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid‐Induced Constipation in Patients with Chronic Noncancer Pain. Pain Practice. 17(6). 820–828.
11.
Tenke, Péter, Steven Joniau, Karolien Goffin, et al.. (2014). Correlation of Technetium Tc99m trofolastat chloride (MIP-1404) uptake using SPECT/CT with histopathology: A phase 2 study of prostate cancer (PCa) patients undergoing radical prostatectomy (RP) with extended lymph node dissection (ePLND). European Journal of Nuclear Medicine and Molecular Imaging. 41.
12.
Rotshteyn, Yakov, François Mercier, René Bruno, et al.. (2013). Correlation of PSMA ADC exposure with reduction in tumor growth rate determined using serial PSA measurements from a phase I clinical trial.. Journal of Clinical Oncology. 31(15_suppl). e16047–e16047.
13.
Lipman, Arthur G., Sloan Beth Karver, Gail Austin Cooney, Nancy Stambler, & Robert J. Israel. (2011). Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness: A 3-Month Open-Label Treatment Extension Study. Journal of Pain & Palliative Care Pharmacotherapy. 25(2). 136–145.
14.
Anissian, Lucas, et al.. (2011). Subcutaneous methylnaltrexone for treatment of acute opioid‐induced constipation: Phase 2 study in rehabilitation after orthopedic surgery. Journal of Hospital Medicine. 7(2). 67–72.
15.
Yu, Chang Sik, Ho-Kyung Chun, Nancy Stambler, et al.. (2011). Safety and Efficacy of Methylnaltrexone in Shortening the Duration of Postoperative Ileus Following Segmental Colectomy: Results of Two Randomized, Placebo-Controlled Phase 3 Trials. Diseases of the Colon & Rectum. 54(5). 570–578.
16.
Parkman, Henry P., Satish S.C. Rao, James C. Reynolds, et al.. (2003). Neurotrophin-3 Improves Functional Constipation. The American Journal of Gastroenterology. 98(6). 1338–1347.
17.
Coulie, Bernard, Lawrence A. Szarka, Michael Camilleri, et al.. (2000). Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology. 119(1). 41–50.
18.
Cedarbaum, Jesse M., et al.. (1999). The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences. 169(1-2). 13–21.
19.
Scarlata, Debra, et al.. (1999). A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. Journal of the Neurological Sciences. 169(1-2). 118–125.
20.
Cedarbaum, Jesse M. & Nancy Stambler. (1997). Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. Journal of the Neurological Sciences. 152. s1–s9.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Robert D. Henderson Breakdown of academic impact, for papers by Klaus Tatsch Breakdown of academic impact, for papers by Richard J. Barohn Breakdown of academic impact, for papers by David Lacomis Breakdown of academic impact, for papers by Teresa Ribalta Breakdown of academic impact, for papers by Julia E. Crook Breakdown of academic impact, for papers by Gordon Gilbert Breakdown of academic impact, for papers by Jun Takahashi Breakdown of academic impact, for papers by David Hilton‐Jones Breakdown of academic impact, for papers by Shigeru Tsunoda